Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1964 1
1967 1
1969 2
1970 1
1971 1
1972 2
1974 1
1975 4
1976 10
1977 8
1978 6
1979 9
1980 13
1981 13
1982 10
1983 11
1984 19
1985 25
1986 10
1987 13
1988 15
1989 16
1990 22
1991 33
1992 20
1993 35
1994 44
1995 39
1996 38
1997 42
1998 43
1999 42
2000 44
2001 43
2002 38
2003 52
2004 58
2005 52
2006 53
2007 49
2008 70
2009 47
2010 56
2011 51
2012 79
2013 69
2014 80
2015 67
2016 57
2017 81
2018 66
2019 82
2020 103
2021 101
2022 108
2023 90
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,972 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous histiocytoses in children.
Fraitag S, Emile JF. Fraitag S, et al. Histopathology. 2022 Jan;80(1):196-215. doi: 10.1111/his.14569. Histopathology. 2022. PMID: 34958507 Review.
Until recently, cutaneous histiocytoses were classified according to the immunophenotype of the pathological cells, with differentiation between Langerhans cell histiocytosis (LCH) [CD1a+, CD207 (langerin)+] and non-Langerhans cell histiocytosis (CD68+, CD163+, CD1a …
Until recently, cutaneous histiocytoses were classified according to the immunophenotype of the pathological cells, with differentiation bet …
Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis.
Krooks J, Minkov M, Weatherall AG. Krooks J, et al. J Am Acad Dermatol. 2018 Jun;78(6):1035-1044. doi: 10.1016/j.jaad.2017.05.059. J Am Acad Dermatol. 2018. PMID: 29754885 Review.
Langerhans cell histiocytosis (LCH) is an inflammatory neoplasia of myeloid precursor cells driven by mutations in the mitogen-activated protein kinase pathway. ...
Langerhans cell histiocytosis (LCH) is an inflammatory neoplasia of myeloid precursor cells driven by mutations in the mitogen-activa …
Pulmonary Langerhans' cell histiocytosis in adults.
Radzikowska E. Radzikowska E. Adv Respir Med. 2017;85(5):277-289. doi: 10.5603/ARM.a2017.0046. Epub 2017 Oct 30. Adv Respir Med. 2017. PMID: 29083024 Free article. Review.
Pulmonary Langerhans' cell histiocytosis (PLCH) is a rare disorder of unknown cause characterised by the infiltration of the lungs and other organs by the bone marrow derived Langerhans' cells, which carry mutations of BRAF gene and/or NRAS, KRAS and MAP2K1 genes. ...
Pulmonary Langerhans' cell histiocytosis (PLCH) is a rare disorder of unknown cause characterised by the infiltration of the lungs an …
Histiocytosis.
Rocamora-Blanch G, Climent F, Solanich X. Rocamora-Blanch G, et al. Med Clin (Barc). 2023 Aug 25;161(4):166-175. doi: 10.1016/j.medcli.2023.05.001. Epub 2023 May 30. Med Clin (Barc). 2023. PMID: 37263840 Review. English, Spanish.
Histiocytosis is a group of rare diseases characterized by inflammation and accumulation of cells derived from monocytes and macrophages in different tissues. ...During the last decade, some mutations have been identified in the affected tissue that condition activation of …
Histiocytosis is a group of rare diseases characterized by inflammation and accumulation of cells derived from monocytes and macropha …
The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.
Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. Goyal G, et al. Mayo Clin Proc. 2019 Oct;94(10):2054-2071. doi: 10.1016/j.mayocp.2019.02.023. Epub 2019 Aug 28. Mayo Clin Proc. 2019. PMID: 31472931
Histiocytic neoplasms, a rare and heterogeneous group of disorders, primarily include Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Due to their diverse clinical manifestations, the greatest challenge posed by these neoplasms is the est …
Histiocytic neoplasms, a rare and heterogeneous group of disorders, primarily include Erdheim-Chester disease, Langerhans cell histiocyto …
Neurological Manifestations of Histiocytic Disorders.
Banks SA, Sartori Valinotti JC, Go RS, Abeykoon JP, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Bennani NN, Shah MV, Rech KL, Tobin WO; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology. Banks SA, et al. Curr Neurol Neurosci Rep. 2023 Jun;23(6):277-286. doi: 10.1007/s11910-023-01272-4. Epub 2023 May 20. Curr Neurol Neurosci Rep. 2023. PMID: 37209319 Review.
PURPOSE OF REVIEW: Histiocytic disorders, including Erdheim-Chester disease (ECD), Langerhans cell histiocytosis (LCH), and Rosai-Dorfman disease (RDD), are rare neoplasms that may present with a spectrum of neurologic involvement. ...
PURPOSE OF REVIEW: Histiocytic disorders, including Erdheim-Chester disease (ECD), Langerhans cell histiocytosis (LCH), and Rosai-Dor …
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
Salama HA, Jazieh AR, Alhejazi AY, Absi A, Alshieban S, Alzahrani M, Alaskar A, Gmati G, Damlaj M, Abuelgasim KA, Alghamdi A, Alahmari B, Almugairi A, Alzahrani H, Bazarbachi A, Musa MOH, Goyal G. Salama HA, et al. Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e66-e75. doi: 10.1016/j.clml.2020.08.007. Epub 2020 Aug 18. Clin Lymphoma Myeloma Leuk. 2021. PMID: 32943371 Free PMC article. Review.
In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis), we created this document based …
In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell …
Langerhans cell histiocytosis.
Margo CE, Goldman DR. Margo CE, et al. Surv Ophthalmol. 2008 Jul-Aug;53(4):332-58. doi: 10.1016/j.survophthal.2008.04.007. Surv Ophthalmol. 2008. PMID: 18572052 Review.
More recently, Langerhans cell histiocytosis has been unified into a single concept, though the disease continues to defy traditional classification. By most accounts, Langerhans cell histiocytosis appears to be a morphologically benign proliferation of inflammatory …
More recently, Langerhans cell histiocytosis has been unified into a single concept, though the disease continues to defy traditional …
Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.
Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, Egeler RM, Janka G, Micic D, Rodriguez-Galindo C, Van Gool S, Visser J, Weitzman S, Donadieu J; Euro Histio Network. Haupt R, et al. Pediatr Blood Cancer. 2013 Feb;60(2):175-84. doi: 10.1002/pbc.24367. Epub 2012 Oct 25. Pediatr Blood Cancer. 2013. PMID: 23109216 Free PMC article.
These guidelines for the management of patients up to 18 years with Langerhans cell histiocytosis (LCH) have been set up by a group of experts involved in the Euro Histio Net project who participated in national or international studies and in peer reviewed publications. . …
These guidelines for the management of patients up to 18 years with Langerhans cell histiocytosis (LCH) have been set up by a group o …
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
Geerlinks AV, Abla O. Geerlinks AV, et al. Paediatr Drugs. 2023 Jul;25(4):399-409. doi: 10.1007/s40272-023-00569-8. Epub 2023 May 19. Paediatr Drugs. 2023. PMID: 37204611 Review.
Histiocytic disorders are rare diseases defined by the clonal accumulation of a macrophage or dendritic cell origin. These disorders include Langerhans cell histiocytosis, Erdheim-Chester disease, juvenile xanthogranuloma, malignant histiocytoses, and Rosai-Dorfman-Destomb …
Histiocytic disorders are rare diseases defined by the clonal accumulation of a macrophage or dendritic cell origin. These disorders include …
1,972 results